AGRX — Agile Therapeutics Share News
0.000.00%
Last trade - 00:00- $10.43m
- $7.58m
- $19.59m
Agile Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Brief: Agile Therapeutics Reports Fourth Quarter & Full Year 2021 Financial Results
Agile Therapeutics Inc expected to post a loss of 15 cents a share - Earnings Preview
Brief: Agile Therapeutics Announces $4.85 Million Registered Direct Offering
Agile Therapeutics Inc expected to post a loss of 15 cents a share - Earnings Preview
Brief: Agile Therapeutics Inc - On Nov 9, Received A Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Brief: Agile Therapeutics Posts Q3 Loss Per Share Of $0.18
Agile Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Agile Therapeutics Appoints Josephine Torrente To Board
Agile Therapeutics slumps on stock, warrants deal
Brief: Agile Therapeutics Announces Pricing Of $22,666,650 Underwritten Public Offering Of Common Stock And Warrants
Agile Therapeutics drops after announcing stock offering
Brief: Agile Announces Proposed Underwritten Public Offering Of Common Stock, Warrants
Brief: Agile Therapeutics Estimates Net Sales In Q3 Of 2021 Will Be In Range Of $1.4 Million To $1.6 Million
Brief: Agile Therapeutics Partners With Telehealth Service, Pandia Health, To Increase Women’S Access To Twirla® Transdermal System
U.S. RESEARCH ROUNDUP-Ati Physical Therapy, Atlantic Capital Bancshares, Medallia
Agile Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Agile Therapeutics Reports Q2 2021 Financial Results
Agile Therapeutics Inc expected to post a loss of 22 cents a share - Earnings Preview